Skip to main content
LXEO filings

Corporate insider profile

Narinder Pal Bhalla Filing Activity

Latest reported as Chief Medical Officer of Lexeo Therapeutics, Inc. (LXEO).

Purchase filings
0
Reported companies
1
Net open-market value
-$98,592.52
Latest transaction
Jul 1, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 1, 2026Lexeo Therapeutics, Inc. (LXEO)Chief Medical OfficerSale22,306$4.42$98,593